ADALIMUMAB

Open Access
Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry
Leslie R. Harrold, Jenny Griffith, Patrick Zueger, Heather J. Litman, Bernice Gershenson, Syed S. Islam, Christine J. Barr, Dianlin Guo, Jonathan Fay and Jeffrey D. Greenberg

The Journal of Rheumatology July 1 2020, 47 (7) 959-967; DOI: https://doi.org/10.3899/jrheum.190260
You have access
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
Gurjit S. Kaeley, Daryl K. MacCarter, Aileen L. Pangan, Xin Wang, Jasmina Kalabic and Veena K. Ranganath

The Journal of Rheumatology December 1 2018, 45 (12) 1628-1635; DOI: https://doi.org/10.3899/jrheum.171232
You have access
Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis
Linda A. Bradbury, Kelly A. Hollis, Benoît Gautier, Sateesh Shankaranarayana, Philip C. Robinson, Nivene Saad, Kim-Anh Lê Cao and Matthew A. Brown

The Journal of Rheumatology June 1 2018, 45 (6) 771-778; DOI: https://doi.org/10.3899/jrheum.170312
Open Access
Performance of 3 Enthesitis Indices in Patients with Peripheral Spondyloarthritis During Treatment with Adalimumab
Philip J. Mease, Filip Van den Bosch, Joachim Sieper, Yinglin Xia, Aileen L. Pangan and In-Ho Song

The Journal of Rheumatology May 1 2017, 44 (5) 599-608; DOI: https://doi.org/10.3899/jrheum.160387
You have access
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study
Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Kenya Terabe, Yuichiro Yabe, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Yasuhide Kanayama, Takeshi Oguchi, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi and Naoki Ishiguro

The Journal of Rheumatology August 1 2016, 43 (8) 1475-1479; DOI: https://doi.org/10.3899/jrheum.151006
Open Access
Methotrexate Dosage Reduction Upon Adalimumab Initiation: Clinical and Ultrasonographic Outcomes from the Randomized Noninferiority MUSICA Trial
Gurjit S. Kaeley, Amy M. Evangelisto, Midori J. Nishio, Sandra L. Goss, Shufang Liu, Jasmina Kalabic and Hartmut Kupper

The Journal of Rheumatology August 1 2016, 43 (8) 1480-1489; DOI: https://doi.org/10.3899/jrheum.151009
You have access
Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings
Florenzo Iannone, Simona Lopriore, Romano Bucci, Giuseppe Lopalco, Angela Chialà, Luca Cantarini and Giovanni Lapadula

The Journal of Rheumatology May 1 2016, 43 (5) 911-917; DOI: https://doi.org/10.3899/jrheum.151042
Open Access
Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
Frank Behrens, Michaela Koehm, Uta Arndt, Bianca M. Wittig, Gerd Greger, Diamant Thaçi, Eva Scharbatke, Hans-Peter Tony and Harald Burkhardt

The Journal of Rheumatology March 1 2016, 43 (3) 632-639; DOI: https://doi.org/10.3899/jrheum.141596
You have access
Clinical Remission in Patients with Active Psoriatic Arthritis Treated with Adalimumab and Correlations in Joint and Skin Manifestations
Filip Van den Bosch, Arthur Kavanaugh, Martina Kron, Hartmut Kupper and Philip J. Mease

The Journal of Rheumatology June 1 2015, 42 (6) 952-959; DOI: https://doi.org/10.3899/jrheum.140312
You have access
Prevalence of TNF-α Blocker Immunogenicity in Psoriatic Arthritis
Michael Zisapel, Devy Zisman, Noa Madar-Balakirski, Uri Arad, Hagit Padova, Hagit Matz, Hagit Maman-Sarvagyl, Ilana Kaufman, Daphna Paran, Joy Feld, Ira Litinsky, Irena Wigler, Dan Caspi and Ori Elkayam

The Journal of Rheumatology January 1 2015, 42 (1) 73-78; DOI: https://doi.org/10.3899/jrheum.140685

Main menu

User menu

Search

ADALIMUMAB

Pages

Content

Resources

Subscribers

More